Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03479502 · ClinicalTrials.gov registry record · Phase 4
Intra-articular Doxycycline: A Novel Treatment of Adhesive Capsulitis
A Phase 4 study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 1
- Enrollment target
NCT03479502 is a Phase 4 study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 1 participants.
The verdict
NCT03479502, a Phase 4 study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1 participants
- Enrollment target
Study Summary
We will recruit a total of 40 patients from the Vanderbilt Sports Medicine Clinics who have been diagnosed with adhesive capsulitis and have not undergone any previous treatment. The 40 patients will be randomized, with 20 in the control group of 3 intra-articular injections of 40mg Methylprednisolone spaced every two weeks, and 20 in the experimental group of 3 intra-articular injection of 50mg doxycycline spaced every two weeks. Both groups will begin a standardized physical therapy program within a pain-free range of motion 4 weeks after the initiation of treatment. We will prospectively follow patients for one year, with follow-up at 6 weeks, 12 weeks, 6 months, and 12 months after the initiation of treatment. Outcomes will be measured using the American Shoulder and Elbow Score (ASES) and objective measurements of shoulder range of motion, which will be collected by the treating physician. Both the patients and physicians participating in the study will be blinded.
Interventions
- DRUG Methylprednisolone Injectable Product
- DRUG Doxycycline Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-03-05 |
| Est. Completion | 2022-02-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03479502
The ClinicalTrials.gov registry entry for NCT03479502 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Methylprednisolone Injectable Product is the first listed.
NCT03479502 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03479502 about?
NCT03479502 is a clinical study titled "Intra-articular Doxycycline: A Novel Treatment of Adhesive Capsulitis". We will recruit a total of 40 patients from the Vanderbilt Sports Medicine Clinics who have been diagnosed with adhesive capsulitis and have not undergone any previous treatment. The 40 patients will be randomized, with 20 in the control group of 3 intra-articular injections of 40mg Methylprednisolo...
What is the current status of trial NCT03479502?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1 participants. The study started on 2018-03-05. Estimated completion is 2022-02-08.
What interventions are being tested in trial NCT03479502?
The interventions under investigation include: Methylprednisolone Injectable Product (DRUG), Doxycycline Injection (DRUG).
Who is sponsoring clinical trial NCT03479502?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.